Retatrutide, also known as LY3437943, is an investigational synthetic peptide
Improved Appetite Control: By supporting appetite regulation, GLP-1 therapy helps reduce cravings and encourages consistent nutritional habits
Nausea, vomiting, diarrhea, constipation, and reduced appetite can occur
Treatment guidelines, therefore, give two potential approaches for intensifying insulin therapy: the addition of a RAI, either as an additional prandial injection or as part of a premixed insulin formula
In addition, HDL with low surface free cholesterol and sphingomyelin are more efficient at accepting lipid hydroperoxides (745,853)
The primary mechanism of action involves enhancing glucose-dependent insulin secretion from pancreatic beta cells while simultaneously suppressing inappropriate glucagon release